Churg-Strauss Syndrome - 25 Studies Found
Not yet recruiting |
: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study : Asthma : 2016-10-17 : Drug: Reslizumab All subjects will receive Reslizumab |
Not yet recruiting |
: PRO Development for ANCA Associated Vasculitis :
|
Completed |
: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides :
: |
Recruiting |
: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study : Asthma : 2016-12-11 : Drug: Benralizumab one injection 30 mg under the subjects skin every 4 weeks for 8 weeks and then every |
Recruiting |
: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides :
: |
Completed |
: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome :
|
Completed |
: Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years :
|
Completed |
: The ANCA Vasculitis Questionnaire (AAV-PRO©) :
|
Completed |
: Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases :
|
Recruiting |
: VCRC Tissue Repository :
|